Are you planning for the end of the Brexit Transition Period?
Are you planning for the end of the Brexit Transition Period? 19th November 2020

Are you planning for the end of the Brexit Transition Period? (Nov 2020)

 

As the end of the Transition Period on 31st December 2020 draws ever closer, pharmaceutical companies are preparing for life outside the EU Single Market and Customs Union. Holding additional stock could provide a buffer against any potential border disruption that could occur during the transition to the controls that will be implemented on 1st January 2021.

 

 

Recent advice from the Department of Health and Social Care suggests that companies make stockpiling a key part of contingency planning. If you are planning to hold additional stock in line with this recommendation, we can offer MHRA regulated warehouse space for storing products in the UK available now. We can also provide fully temperature-controlled transportation for next day delivery that is aligned to GDP.

 

 

Other latest news
https://www.mawdsleys.co.uk/news/strides-pharma-uk-choose-mawdsleys-as-their-distributor-to-hospitals/ thumbnail image Strides Pharma UK choose Mawdsleys as their distributor to hospitals

Mawdsleys will be distributing Strides Pharma UK products to English hospitals as part of CMU contract   Mawdsleys are delighted to be assisting Strides Pharma UK Ltd in distributing the following products to English hospitals for CMU contract CM/PHG/15/5467/01:   Description: Prednisolone Tabs 5mg Pack: 28 PIP Code: 1106046 EAN Code: 005060057401422 Description: Azathioprine Tabs 50mg…

Read more
https://www.mawdsleys.co.uk/news/mawdsleys-sources-compassionate-access-for-critically-ill-patient/ thumbnail image Mawdsleys secures compassionate access for critically ill patient

  We are extremely proud of our patient-centric unrivalled service at Mawdsleys.   Over a recent bank holiday, our unlicensed team received an urgent, time-sensitive order request from a leading NHS children’s hospital in the North West to secure compassionate access to a medicine on clinical trial in North America…

Read more
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.